Vasostrict

Vasostrict · pharmadog

Patent cliff

source: FDA Orange Book

first barrier falls

Jan 30, 2035

~8.6 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (49)

Sep 27, 2044formulationUS 12447190
Sep 27, 2044formulationUS 12447190
Jan 30, 2035method-of-use (U-1857)US 10010575
Jan 30, 2035method-of-use (U-1857)US 10010575
Jan 30, 2035method-of-use (U-1857)US 10010575
Jan 30, 2035method-of-use (U-1857)US 10010575
Jan 30, 2035formulationUS 12186362
Jan 30, 2035formulationUS 12186362
Jan 30, 2035formulationUS 12186362
Jan 30, 2035formulationUS 12186362
Jan 30, 2035method-of-use (U-1857)US 9375478
Jan 30, 2035method-of-use (U-1857)US 9375478
Jan 30, 2035method-of-use (U-1857)US 9687526
Jan 30, 2035method-of-use (U-1857)US 9687526
Jan 30, 2035method-of-use (U-1857)US 9744209
Jan 30, 2035method-of-use (U-1857)US 9744209
Jan 30, 2035method-of-use (U-1857)US 9744239
Jan 30, 2035method-of-use (U-1857)US 9744239
Jan 30, 2035formulationUS 9750785
Jan 30, 2035formulationUS 9750785
Jan 30, 2035formulationUS 9919026
Jan 30, 2035formulationUS 9919026
Jan 30, 2035formulationUS 9919026
Jan 30, 2035formulationUS 9919026
Jan 30, 2035method-of-use (U-1857)US 9925233
Jan 30, 2035method-of-use (U-1857)US 9925233
Jan 30, 2035method-of-use (U-1857)US 9925233
Jan 30, 2035method-of-use (U-1857)US 9925233
Jan 30, 2035method-of-use (U-1857)US 9925234
Jan 30, 2035method-of-use (U-1857)US 9925234
Jan 30, 2035method-of-use (U-1857)US 9925234
Jan 30, 2035method-of-use (U-1857)US 9925234
Jan 30, 2035method-of-use (U-1857)US 9937223
Jan 30, 2035method-of-use (U-1857)US 9962422
Jan 30, 2035method-of-use (U-1857)US 9962422
Jan 30, 2035method-of-use (U-1857)US 9962422
Jan 30, 2035method-of-use (U-1857)US 9962422
Jan 30, 2035method-of-use (U-1857)US 9968649
Jan 30, 2035method-of-use (U-1857)US 9968649
Jan 30, 2035method-of-use (U-1857)US 9968649
Jan 30, 2035method-of-use (U-1857)US 9968649
Jan 30, 2035method-of-use (U-1857)US 9974827
Jan 30, 2035method-of-use (U-1857)US 9974827
Jan 30, 2035method-of-use (U-1857)US 9974827
Jan 30, 2035method-of-use (U-1857)US 9974827
Jan 30, 2035method-of-use (U-1857)US 9981006
Jan 30, 2035method-of-use (U-1857)US 9981006
Jan 30, 2035method-of-use (U-1857)US 9981006
Jan 30, 2035method-of-use (U-1857)US 9981006

vasopressin

all catalysts(0)

News(0)

Patent cliff

patents (49)

comments(0)

Report a data issue

Trials studying vasopressin